+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Cystic fibrosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cystic fibrosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Non-Cystic Fibrosis Bronchiectasis (NCFB) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Non-Cystic Fibrosis Bronchiectasis (NCFB) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages +
  • Global
From
Autoimmune pulmonary alveolar proteinosis (aPAP) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Autoimmune pulmonary alveolar proteinosis (aPAP) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Non-Cystic Fibrosis Bronchiectasis (NCFB) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Non-Cystic Fibrosis Bronchiectasis (NCFB) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Alpha- Antitrypsin Deficiency - Epidemiology Forecast to 2032 - Product Thumbnail Image

Alpha- Antitrypsin Deficiency - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Sarcopenia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sarcopenia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 419 Pages
  • Global
From
Acute Respiratory Distress Syndrome (ARDS) Market Insight, Epidemiology and Market Forecast -2030 - Product Thumbnail Image

Acute Respiratory Distress Syndrome (ARDS) Market Insight, Epidemiology and Market Forecast -2030

  • Report
  • December 2020
  • 314 Pages
  • Global
From
Ofev (Nintedanib) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Ofev (Nintedanib) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Esbriet (Pirfenidone) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Esbriet (Pirfenidone) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
Epinephrine Autoinjector Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Epinephrine Autoinjector Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 110 Pages
  • Global
From
Bronchitis Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Bronchitis Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 112 Pages
  • Global
From
Asthma and COPD Devices Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027) - Product Thumbnail Image

Asthma and COPD Devices Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Japan Respiratory Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F - Product Thumbnail Image

Japan Respiratory Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • Report
  • September 2024
  • 82 Pages
  • Japan
From
Lower Respiratory Tract Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Lower Respiratory Tract Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 181 Pages
  • Global
From
Levofloxacin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Levofloxacin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 188 Pages
  • Global
From
Cough Hypersensitivity Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Cough Hypersensitivity Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Respiratory Disease Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 181 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more